STEPHANIE SEMAAN: Open Payments
NPI 1801403043 · METHUEN, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$573 in 40 payments from 7 companies in 2025. Trend: 2023 $991 · 2024 $817 · 2025 $573
Food & beverage: $573
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $304 |
| Lilly USA, LLC | 5 | $112 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $64 |
| GlaxoSmithKline, LLC. | 2 | $42 |
| Novo Nordisk Inc | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Corcept Therapeutics | 1 | $16 |
Products named: VRAYLAR, JARDIANCE, UBRELVY, XIFAXAN, QULIPTA, MOUNJARO, CREON, TRELEGY ELLIPTA.
Industry payments across MA — which companies pay providers there.
